Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor
- PMID: 16955688
Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor
Abstract
Panacos Pharmaceuticals Inc is developing the HIV Gag protein and viral maturation inhibitor bevirimat for the potential oral treatment of HIV infection. Phase II clinical trials are underway and phase III trials expected to commence in 2007.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical